Literature DB >> 28045404

Liver inflammation and fibrosis.

Yukinori Koyama, David A Brenner.   

Abstract

Chronic liver inflammation leads to fibrosis and cirrhosis, which is the 12th leading cause of death in the United States. Hepatocyte steatosis is a component of metabolic syndrome and insulin resistance. Hepatic steatosis may be benign or progress to hepatocyte injury and the initiation of inflammation, which activates immune cells. While Kupffer cells are the resident macrophage in the liver, inflammatory cells such as infiltrating macrophages, T lymphocytes, neutrophils, and DCs all contribute to liver inflammation. The inflammatory cells activate hepatic stellate cells, which are the major source of myofibroblasts in the liver. Here we review the initiation of inflammation in the liver, the liver inflammatory cells, and their crosstalk with myofibroblasts.

Entities:  

Mesh:

Year:  2017        PMID: 28045404      PMCID: PMC5199698          DOI: 10.1172/JCI88881

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  154 in total

1.  Development, differentiation, and maturation of fetal mouse yolk sac macrophages in cultures.

Authors:  M Naito; F Yamamura; S Nishikawa; K Takahashi
Journal:  J Leukoc Biol       Date:  1989-07       Impact factor: 4.962

2.  M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

Authors:  Jinghong Wan; Merieme Benkdane; Fatima Teixeira-Clerc; Stéphanie Bonnafous; Alexandre Louvet; Fouad Lafdil; Françoise Pecker; Albert Tran; Philippe Gual; Ariane Mallat; Sophie Lotersztajn; Catherine Pavoine
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

3.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

4.  Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.

Authors:  Marta B Afonso; Pedro M Rodrigues; Tânia Carvalho; Marta Caridade; Paula Borralho; Helena Cortez-Pinto; Rui E Castro; Cecília M P Rodrigues
Journal:  Clin Sci (Lond)       Date:  2015-06-15       Impact factor: 6.124

5.  Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).

Authors:  Mario E Lacouture; John C Morris; Donald P Lawrence; Antoinette R Tan; Thomas E Olencki; Geoffrey I Shapiro; Bruce J Dezube; Jay A Berzofsky; Frank J Hsu; Joan Guitart
Journal:  Cancer Immunol Immunother       Date:  2015-01-13       Impact factor: 6.968

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

7.  Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.

Authors:  Claudia Mitchell; Dominique Couton; Jean-Pierre Couty; Marie Anson; Anne-Marie Crain; Vinciane Bizet; Laurent Rénia; Stanislas Pol; Vincent Mallet; Hélène Gilgenkrantz
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

8.  Effects of oral intake of hydrogen water on liver fibrogenesis in mice.

Authors:  Yukinori Koyama; Kojiro Taura; Etsuro Hatano; Kazutaka Tanabe; Gen Yamamoto; Kojiro Nakamura; Kenya Yamanaka; Koji Kitamura; Masato Narita; Hiromitsu Nagata; Atsuko Yanagida; Taku Iida; Keiko Iwaisako; Hikohito Fujinawa; Shinji Uemoto
Journal:  Hepatol Res       Date:  2013-06-18       Impact factor: 4.288

9.  Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?

Authors:  E Ryan; V Byrnes; B Coughlan; A-M Flanagan; S Barrett; J C O'Keane; J Crowe
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.

Authors:  Hong Ling; Eric Roux; Donna Hempel; Jingzang Tao; Mandy Smith; Scott Lonning; Anna Zuk; Cynthia Arbeeny; Steve Ledbetter
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more
  270 in total

1.  Perilipin 5 and liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.

Authors:  Jianguo Lin; Shizhong Zheng; Alan D Attie; Mark P Keller; David A Bernlohr; William S Blaner; Elizabeth P Newberry; Nicholas O Davidson; Anping Chen
Journal:  J Lipid Res       Date:  2018-01-09       Impact factor: 5.922

2.  Stevioside inhibits experimental fibrosis by down-regulating profibrotic Smad pathways and blocking hepatic stellate cell activation.

Authors:  Sael Casas-Grajales; Diana Alvarez-Suarez; Erika Ramos-Tovar; Laura Dayana Buendía-Montaño; Karina Reyes-Gordillo; Javier Camacho; Víctor Tsutsumi; M Raj Lakshman; Pablo Muriel
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-01-10       Impact factor: 4.080

3.  Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.

Authors:  Alejandro Torres-Hernandez; Wei Wang; Yuri Nikiforov; Karla Tejada; Luisana Torres; Aleksandr Kalabin; Yue Wu; Muhammad Israr Ul Haq; Mohammed Y Khan; Zhen Zhao; Wenyu Su; Jimmy Camargo; Mautin Hundeyin; Brian Diskin; Salma Adam; Juan A Kochen Rossi; Emma Kurz; Berk Aykut; Sorin A A Shadaloey; Joshua Leinwand; George Miller
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

4.  Resolving inflammation in nonalcoholic steatohepatitis.

Authors:  Matthew Spite
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

Review 5.  Interleukin-17: Friend or foe in organ fibrosis.

Authors:  Kritika Ramani; Partha S Biswas
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

6.  Analysis of key genes and related transcription factors in liver fibrosis based on bioinformatic technology.

Authors:  Xue Yang; Qi-Ni Cheng; Jiang-Feng Wu; Wen-Bing Ai; Lan Ma
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

7.  Complement factor H-deficient mice develop spontaneous hepatic tumors.

Authors:  Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Natalie J Serkova; Peter M Smith-Jones; Eric T Clambey; Raphael A Nemenoff; Joshua M Thurman
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

8.  Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.

Authors:  Zengdun Shi; Mudan Ren; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

9.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

Review 10.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.